Clinical experience with ceftazidime/avibactam in patients with severe infections, including meningitis and lung abscesses, caused by extensively drug-resistant Pseudomonas aeruginosa

被引：33
|
作者：
Xipell, Marc [1 ]
Bodro, Marta [1 ]
Marco, Francesc [2 ]
Losno, Ricardo A. [1 ]
Cardozo, Celia [1 ]
Soriano, Alex [1 ]
机构：
[1] Univ Barcelona, Hosp Clin IDIBAPS, Dept Infect Dis, Villarroel 170, E-08036 Barcelona, Spain
[2] Univ Barcelona, Hosp Clin ISGLOBAL, Dept Microbiol, Barcelona, Spain
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2017年 / 49卷 / 02期
关键词：
AVIBACTAM; MORTALITY;
D O I：
10.1016/j.ijantimicag.2016.11.005
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：266 / 268
页数：4
相关论文
共 50 条
  • [1] Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa
    Rodriguez-Nunez, Olga
    Ripa, Marco
    Morata, Laura
    de la Calle, Cristina
    Cardozo, Celia
    Feher, Csaba
    Pellice, Martina
    Valcarcel, Andrea
    Puerta-Alcalde, Pedro
    Marco, Francesc
    Garcia-Vidal, Carolina
    del Rio, Ana
    Soriano, Alex
    Antonio Martinez-Martinez, Jose
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2018, 15 : 136 - 139
  • [2] Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa
    Kang, Yixin
    Xie, Lu
    Yang, Jiyong
    Cui, Junchang
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [3] Clinical outcomes of ceftazidime-avibactam in lung transplant recipients with infections caused by extensively drug-resistant gram-negative bacilli
    Chen, Wenhui
    Sun, Lingxiao
    Guo, Lijuan
    Cao, Bin
    Liu, Yingmei
    Zhao, Li
    Lu, Binghuai
    Li, Binbin
    Chen, Jingyu
    Wang, Chen
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (03)
  • [4] Synergistic Activity of Imipenem in Combination with Ceftazidime/Avibactam or Avibactam against Non-MBL-Producing Extensively Drug-Resistant Pseudomonas aeruginosa
    Zhang, Yulin
    Zhao, Jiankang
    Han, Jiajing
    Fan, Yanyan
    Xiong, Zhujia
    Zou, Xiaohui
    Li, Binbin
    Liu, Xinmeng
    Li, Ziyao
    Lu, Binghuai
    Cao, Bin
    MICROBIOLOGY SPECTRUM, 2022, 10 (02):
  • [5] Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature
    Marianna Meschiari
    Iacopo Franconi
    Erica Bacca
    Vincenzo Bianco
    Gabriella Orlando
    Gianluca Cuomo
    Andrea Bedini
    Cristina Mussini
    Infection, 2021, 49 : 549 - 553
  • [6] Ceftazidime-avibactam and intrapleural amikacin therapy for extensively drug-resistant Pseudomonas aeruginosa thoracic empyema A case report
    Chen, Tzu-Ting
    Chen, Shu-Mei
    Liu, Hsin-Yi
    MEDICINE, 2022, 101 (24) : E29467
  • [7] Clinical experience with ceftazidime/avibactam for the treatment of extensively drug-resistant or pandrug-resistant Klebsiella pneumoniae in neonates and children
    Gundeslioglu, Ozlem Ozgur
    Haytoglu, Zeliha
    Gumus, Hatice Hale
    Ekinci, Faruk
    Kibar, Filiz
    Cay, Ummuhan
    Alabaz, Derya
    Ozlu, Ferda
    Horoz, Ozden Ozgur
    Yildizdas, Riza Dincer
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (12) : 2361 - 2369
  • [8] Addressing carbapenemase-producing extensively drug-resistant Pseudomonas aeruginosa: the potential of cefiderocol and ceftazidime/avibactam plus aztreonam therapy
    Montero, Maria Milagro
    Domene-Ochoa, Sandra
    Prim, Nuria
    Ferola, Eliana
    Lopez-Causape, Carla
    Gomis-Font, Marian
    Ampuero-Morisaki, Mario F.
    Echeverria, Daniel
    Sorli, Luisa
    Luque, Sonia
    Padilla, Eduardo
    Grau, Santiago
    Oliver, Antonio
    Horcajada, Juan P.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2025,
  • [9] Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections
    Palavutitotai, Nattawan
    Jitmuang, Anupop
    Tongsai, Sasima
    Kiratisin, Pattarachai
    Angkasekwinai, Nasikarn
    PLOS ONE, 2018, 13 (02):
  • [10] Extensively drug-resistant Pseudomonas aeruginosa ventriculitis and meningitis treated with intrathecal colistin
    Karagoz, Gul
    Kadanali, Ayten
    Dede, Behiye
    Sahin, Omer Torun
    Comoglu, Senol
    Altug, Sevda Babacan
    Naderi, Sait
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (01) : 93 - 94
12345